Frontier Milestones Invest BETA
EN KO
Not investment advice · Market data delayed ≥ 15 min · Technical data last verified 2026-06-22 · No ratings, price targets or buy / sell signals are shown
← Screener

Commonwealth Fusion Systems

Nuclear Fusion·Private
Tech Score51EmergingOPINION
Goal milestone Net-positive, grid-connected fusion power

MIT spinout building SPARC, a high-field tokamak targeting net energy gain (Q>1).

Founded2018 HQDevens, MA, US Websitecfs.energy ↗

Technology ↔ market gap

Verified technical progress over time. Market valuation overlays once delayed data connects.

Technical progress Market valuation
1 2 3 4 5 Current 3.0

Trajectory builds as milestones accumulate.

Verified stage
3.0 / 5
05
Market-impliedAwaiting market data
GapOPINIONAwaiting market data

Catalysts

Stock-moving events from the newsroom feed — facts, not advice. No rating, no price target.

2026-07-30
Capital
Commonwealth Fusion raises another $1B — total to $4B, and a new class of investors shows up
2026-07-13
Guidance
Fusion funding hits a record $4.48B in a year — up 69%, total now $14.24B
2026-07-01
Partnership
CFS becomes the first international partner in the UK's LIBRTI tritium program
2026-06-23
Guidance
Fusion supply-chain spending up 24% year over year

From the verified Frontier Milestones dataset.

2026-06
Stage 3
ARC physics validated in 5 peer-reviewed papers
source ↗
2027
Stage 3
SPARC — net energy gain Q>1 (target)
source ↗
Distance to goal 60%
Net-positive, grid-connected fusion power

Market data

Cumulative funding$2.0B

Quantitative factors

Computed once market data connects (price, market cap, runway).

Commentary

No analyst commentary published yet.

Commentary reflects one analyst’s view and is not a recommendation. It is presented alongside factual data and is explicitly labelled opinion.

Discussion0

Member discussion. Not investment advice, solicitation, or a recommendation.

Loading…

LICENSE-GATED Ratings & price targets are not shown. FM Invest does not display buy / hold / sell ratings or price targets until investment-advisory licensing is in place. The schema exists and is gated to zero exposure until then.

For information only. Not investment advice and not a solicitation. Market data is delayed and provided “as is”; technical data is read from the Frontier Milestones verified dataset.